BA/BE study in clinical research

Bioavailability (BA) and Bioequivalence (BE) studies play a pivotal role in the development and approval of generic drugs, biosimilars, and novel formulations. In clinical research, BA studies measure the rate and extent to which the active pharmaceutical ingredient reaches systemic circulation, while BE studies compare that performance between test and reference formulations under comparable conditions. This guide is designed especially for students in pharmaceutical sciences and clinical research, providing you a comprehensive overview of protocols, regulatory requirements (FDA, EMA, CDSCO), study designs (crossover, parallel), statistical considerations, and real-world case examples.

BA = Bioavailability studies

Measure how much and how fast the drug (active ingredient) becomes available in the blood after administration.

BE = Bioequivalence studies

Compare a generic drug with a reference branded drug to show they act the same in the body (similar rate & extent of absorption).